Reveal for Lower GI

Reveal Lower GI risks hiding in plain sight

Use AI to Detect Lower GI Disorders

With an aging population and increasing provider shortage, clinicians are struggling to keep up with demand for care, while being asked to deliver more with less. Provider organizations broadly struggle to identify and prioritize patients who have, or will have, the greatest need for lower GI care.

0th
leading cause of cancer death in the U.S. is Colorectal Cancer (CRC)
0%
of age-eligible adults are not current for CRC screening
0%
of CRC deaths could be prevented with screening

AI-Powered Lower GI Detection

Lucem Health Reveal for Lower GI uses your existing data to identify patients who appear to be at a higher risk for lower GI disorders, but who are overdue for standard screening. By leveraging a proven AI algorithm to look far beyond anemia and identify patterns that humans cannot, Reveal for Lower GI helps you detect lower GI disorders earlier, treat them more effectively, and improve both patient outcomes and your bottom line.

Reveal for Lower GI Features

Efficient

Presents a simple list of higher risk patients who should receive priority follow-ups

Intuitive

Excludes predisposing risk factors (such as anemia)

Integrated

Complements and enhances your existing clinical workflows

Security

Secure

Proven data security with HIPAA compliance and SOC 2 certification

The Reveal Difference

  • Uses EHR data and a proven AI model to flag people between 45 and 74 years old who may be at elevated risk for lower gastrointestinal (GI) disorders such as colorectal cancer (CRC)

  • Enables provider organizations to target these patients for earlier detection and intervention, which leads to more successful treatment and better patient outcomes

  • Leverages an AI model that has shown successful results on three continents

  • Creates opportunities for increased revenues in fee-for-service (FFS) scenarios

  • Accelerates CRC detections in value-based care (VBC) arrangements, which helps reduce the need for higher-cost, later-stage treatments

How It Works

See how early detection and intervention can improve outcomes and quality of life for patients enabling treatment before a patient’s a condition may become more difficult and expensive to manage.

The Impact of Colorectal Cancer

According to the CDC colorectal cancer is the fourth leading cause of cancer death in the U.S., but it doesn’t have to be. Few preventive interventions are as reliably effective in reducing avoidable death as screening for colorectal cancer.

Many are working to increase screening rates of colorectal cancer (CRC) in the United States with the goal of achieving 80%. However, approximately 32% of age-eligible U.S. adults do not follow the current CRC screening guidelines.  CRC can even be prevented if asymptomatic polyps and other early-stage cancers are detected and treated early. Better tools and associated clinical outreach are needed to encourage patient compliance, particularly for patients at highest risk.

Published Research

Reveal for Lower GI has been thoroughly studied and tested in a number of different clinical settings to prove real-world efficacy.

Deliver More Proactive Lower GI Care

Find out how you can harness the power of AI to reveal hidden lower GI risks earlier, focus your clinical resources, and improve patient outcomes—without extensive training, adapting your clinical workflows, or undergoing extensive data and systems integration.

Schedule A Conversation